1 | antibodies | 5,951 |
2 | autoantibodies | 839 |
3 | antiserum | 97 |
4 | isotype | 68 |
5 | antisera | 65 |
6 | alloantibodies | 36 |
7 | auto-antibodies | 35 |
8 | gammopathy | 35 |
9 | rotaviruses | 33 |
10 | seroreactivity | 26 |
11 | iggs | 23 |
12 | ≥1:40 | 23 |
13 | moab | 16 |
14 | chalks | 14 |
15 | bomab | 10 |
16 | ≥1:128 | 10 |
17 | allotype | 9 |
18 | calibrators | 9 |
19 | caramels | 9 |
20 | grove | 9 |
21 | ivigs | 9 |
22 | anti-sera | 8 |
23 | hydroxyls | 8 |
24 | videophones | 8 |
25 | allotypes | 7 |
26 | pseudopodia | 7 |
27 | anti-p24 | 6 |
28 | at-4140 | 6 |
29 | autoab | 6 |
30 | t-3761 | 6 |
31 | ≥1:20 | 6 |
32 | anti-nasha | 5 |
33 | iga-levels | 5 |
34 | igm-antibodies | 5 |
35 | isoagglutinins | 5 |
36 | ky-087 | 5 |
37 | march5 | 5 |
38 | mitocans | 5 |
39 | physician-researchers | 5 |
40 | prist | 5 |
41 | 6-hydroxylase | 4 |
42 | lasota | 4 |
43 | ncrc60 | 4 |
44 | neosensitization | 4 |
45 | riboprobes | 4 |
46 | agnoprotein | 3 |
47 | anti-ca15-3 | 3 |
48 | anti-sheep | 3 |
49 | cryoglobulinaemias | 3 |
50 | demethyl-vancomycin | 3 |
51 | luteotrophins | 3 |
52 | monoclonals | 3 |
53 | paraproteins | 3 |
54 | precipitins | 3 |
55 | purpuromycin | 3 |
56 | sit1 | 3 |
57 | stomat-spray | 3 |
58 | storybooks | 3 |
59 | subintegrum | 3 |
60 | 0.5u | 2 |
61 | allo-antigens | 2 |
62 | ampylation | 2 |
63 | anti-inos | 2 |
64 | anti-omps | 2 |
65 | anti-pb19 | 2 |
66 | anti-vp1 | 2 |
67 | bilirubinometry | 2 |
68 | cd133-antibodies | 2 |
69 | cseps | 2 |
70 | effluence | 2 |
71 | histatins | 2 |
72 | puedo | 2 |
73 | resina | 2 |
74 | sensitivity/responsiveness | 2 |
75 | subisotypes | 2 |
76 | thioacetals | 2 |
77 | ≥1:10 | 2 |
78 | ≥1:50 | 2 |
79 | 'above | 1 |
80 | 170k | 1 |
81 | 2,3-dehydratase | 1 |
82 | 3,4-epoxides | 1 |
83 | 4.8x10 | 1 |
84 | 46.2+/-10.8 | 1 |
85 | 5-hydroxymethylforfural | 1 |
86 | amount/frequency | 1 |
87 | anteroposteriorly | 1 |
88 | anti-h-2kk | 1 |
89 | anti-mct4 | 1 |
90 | anti-pr | 1 |
91 | anti-pspa | 1 |
92 | anti-spectrin | 1 |
93 | anti-t- | 1 |
94 | antibody-3 | 1 |
95 | antikeratin | 1 |
96 | apl-igg | 1 |
97 | assay=600 | 1 |
98 | bilirubinometers | 1 |
99 | carm1 | 1 |
100 | catta | 1 |
101 | cross-inhibitions | 1 |
102 | cytotoxic-hyporesponsiveness | 1 |
103 | d4/5 | 1 |
104 | dehydrogenase-a | 1 |
105 | dehydrogenase-ldh | 1 |
106 | deshydrogenase | 1 |
107 | dragées | 1 |
108 | extraction/excretion | 1 |
109 | flotillin-1/2 | 1 |
110 | fragment-variable | 1 |
111 | gammopathies | 1 |
112 | guidelines.to | 1 |
113 | heart-lung-machine | 1 |
114 | heronries | 1 |
115 | hfab | 1 |
116 | igg-agarose | 1 |
117 | immuno-therapies | 1 |
118 | immunosorbents | 1 |
119 | indium-gallium-aluminum-phosphide | 1 |
120 | jyo | 1 |
121 | lyase- | 1 |
122 | medications-recommended | 1 |
123 | midcisternal | 1 |
124 | nose-hoover | 1 |
125 | plasmocytosis | 1 |
126 | platelets.aggregation | 1 |
127 | release-activity | 1 |
128 | surface-distributed | 1 |
129 | titer≥10miu/ml | 1 |
130 | ultrafiltration-ms | 1 |
131 | vegf-antibodies | 1 |
132 | wave-doppler | 1 |
133 | wave-tdi | 1 |
134 | zymosan-a | 1 |
135 | ≥25.7-fold | 1 |
1 | 'above | 1 |
2 | 0.5u | 2 |
3 | 170k | 1 |
4 | 2,3-dehydratase | 1 |
5 | 3,4-epoxides | 1 |
6 | 4.8x10 | 1 |
7 | 46.2+/-10.8 | 1 |
8 | 5-hydroxymethylforfural | 1 |
9 | 6-hydroxylase | 4 |
10 | agnoprotein | 3 |
11 | allo-antigens | 2 |
12 | alloantibodies | 36 |
13 | allotype | 9 |
14 | allotypes | 7 |
15 | amount/frequency | 1 |
16 | ampylation | 2 |
17 | anteroposteriorly | 1 |
18 | anti-ca15-3 | 3 |
19 | anti-h-2kk | 1 |
20 | anti-inos | 2 |
21 | anti-mct4 | 1 |
22 | anti-nasha | 5 |
23 | anti-omps | 2 |
24 | anti-p24 | 6 |
25 | anti-pb19 | 2 |
26 | anti-pr | 1 |
27 | anti-pspa | 1 |
28 | anti-sera | 8 |
29 | anti-sheep | 3 |
30 | anti-spectrin | 1 |
31 | anti-t- | 1 |
32 | anti-vp1 | 2 |
33 | antibodies | 5,951 |
34 | antibody-3 | 1 |
35 | antikeratin | 1 |
36 | antisera | 65 |
37 | antiserum | 97 |
38 | apl-igg | 1 |
39 | assay=600 | 1 |
40 | at-4140 | 6 |
41 | auto-antibodies | 35 |
42 | autoab | 6 |
43 | autoantibodies | 839 |
44 | bilirubinometers | 1 |
45 | bilirubinometry | 2 |
46 | bomab | 10 |
47 | calibrators | 9 |
48 | caramels | 9 |
49 | carm1 | 1 |
50 | catta | 1 |
51 | cd133-antibodies | 2 |
52 | chalks | 14 |
53 | cross-inhibitions | 1 |
54 | cryoglobulinaemias | 3 |
55 | cseps | 2 |
56 | cytotoxic-hyporesponsiveness | 1 |
57 | d4/5 | 1 |
58 | dehydrogenase-a | 1 |
59 | dehydrogenase-ldh | 1 |
60 | demethyl-vancomycin | 3 |
61 | deshydrogenase | 1 |
62 | dragées | 1 |
63 | effluence | 2 |
64 | extraction/excretion | 1 |
65 | flotillin-1/2 | 1 |
66 | fragment-variable | 1 |
67 | gammopathies | 1 |
68 | gammopathy | 35 |
69 | grove | 9 |
70 | guidelines.to | 1 |
71 | heart-lung-machine | 1 |
72 | heronries | 1 |
73 | hfab | 1 |
74 | histatins | 2 |
75 | hydroxyls | 8 |
76 | iga-levels | 5 |
77 | igg-agarose | 1 |
78 | iggs | 23 |
79 | igm-antibodies | 5 |
80 | immuno-therapies | 1 |
81 | immunosorbents | 1 |
82 | indium-gallium-aluminum-phosphide | 1 |
83 | isoagglutinins | 5 |
84 | isotype | 68 |
85 | ivigs | 9 |
86 | jyo | 1 |
87 | ky-087 | 5 |
88 | lasota | 4 |
89 | luteotrophins | 3 |
90 | lyase- | 1 |
91 | march5 | 5 |
92 | medications-recommended | 1 |
93 | midcisternal | 1 |
94 | mitocans | 5 |
95 | moab | 16 |
96 | monoclonals | 3 |
97 | ncrc60 | 4 |
98 | neosensitization | 4 |
99 | nose-hoover | 1 |
100 | paraproteins | 3 |
101 | physician-researchers | 5 |
102 | plasmocytosis | 1 |
103 | platelets.aggregation | 1 |
104 | precipitins | 3 |
105 | prist | 5 |
106 | pseudopodia | 7 |
107 | puedo | 2 |
108 | purpuromycin | 3 |
109 | release-activity | 1 |
110 | resina | 2 |
111 | riboprobes | 4 |
112 | rotaviruses | 33 |
113 | sensitivity/responsiveness | 2 |
114 | seroreactivity | 26 |
115 | sit1 | 3 |
116 | stomat-spray | 3 |
117 | storybooks | 3 |
118 | subintegrum | 3 |
119 | subisotypes | 2 |
120 | surface-distributed | 1 |
121 | t-3761 | 6 |
122 | thioacetals | 2 |
123 | titer≥10miu/ml | 1 |
124 | ultrafiltration-ms | 1 |
125 | vegf-antibodies | 1 |
126 | videophones | 8 |
127 | wave-doppler | 1 |
128 | wave-tdi | 1 |
129 | zymosan-a | 1 |
130 | ≥1:10 | 2 |
131 | ≥1:128 | 10 |
132 | ≥1:20 | 6 |
133 | ≥1:40 | 23 |
134 | ≥1:50 | 2 |
135 | ≥25.7-fold | 1 |
1 | lyase- | 1 |
2 | anti-t- | 1 |
3 | assay=600 | 1 |
4 | ≥1:10 | 2 |
5 | 4.8x10 | 1 |
6 | ≥1:20 | 6 |
7 | at-4140 | 6 |
8 | ≥1:40 | 23 |
9 | ≥1:50 | 2 |
10 | ncrc60 | 4 |
11 | t-3761 | 6 |
12 | carm1 | 1 |
13 | anti-vp1 | 2 |
14 | sit1 | 3 |
15 | flotillin-1/2 | 1 |
16 | anti-ca15-3 | 3 |
17 | antibody-3 | 1 |
18 | anti-p24 | 6 |
19 | anti-mct4 | 1 |
20 | d4/5 | 1 |
21 | march5 | 5 |
22 | ky-087 | 5 |
23 | 46.2+/-10.8 | 1 |
24 | ≥1:128 | 10 |
25 | anti-pb19 | 2 |
26 | dehydrogenase-a | 1 |
27 | zymosan-a | 1 |
28 | anti-nasha | 5 |
29 | pseudopodia | 7 |
30 | resina | 2 |
31 | anti-pspa | 1 |
32 | anti-sera | 8 |
33 | antisera | 65 |
34 | lasota | 4 |
35 | catta | 1 |
36 | hfab | 1 |
37 | bomab | 10 |
38 | moab | 16 |
39 | autoab | 6 |
40 | medications-recommended | 1 |
41 | surface-distributed | 1 |
42 | ≥25.7-fold | 1 |
43 | effluence | 2 |
44 | indium-gallium-aluminum-phosphide | 1 |
45 | fragment-variable | 1 |
46 | heart-lung-machine | 1 |
47 | allotype | 9 |
48 | isotype | 68 |
49 | 6-hydroxylase | 4 |
50 | deshydrogenase | 1 |
51 | 2,3-dehydratase | 1 |
52 | igg-agarose | 1 |
53 | 'above | 1 |
54 | grove | 9 |
55 | apl-igg | 1 |
56 | dehydrogenase-ldh | 1 |
57 | wave-tdi | 1 |
58 | 170k | 1 |
59 | anti-h-2kk | 1 |
60 | midcisternal | 1 |
61 | 5-hydroxymethylforfural | 1 |
62 | titer≥10miu/ml | 1 |
63 | antiserum | 97 |
64 | subintegrum | 3 |
65 | demethyl-vancomycin | 3 |
66 | purpuromycin | 3 |
67 | agnoprotein | 3 |
68 | anti-spectrin | 1 |
69 | antikeratin | 1 |
70 | platelets.aggregation | 1 |
71 | ampylation | 2 |
72 | neosensitization | 4 |
73 | extraction/excretion | 1 |
74 | puedo | 2 |
75 | guidelines.to | 1 |
76 | jyo | 1 |
77 | anti-sheep | 3 |
78 | wave-doppler | 1 |
79 | nose-hoover | 1 |
80 | anti-pr | 1 |
81 | cryoglobulinaemias | 3 |
82 | riboprobes | 4 |
83 | 3,4-epoxides | 1 |
84 | antibodies | 5,951 |
85 | cd133-antibodies | 2 |
86 | vegf-antibodies | 1 |
87 | igm-antibodies | 5 |
88 | auto-antibodies | 35 |
89 | alloantibodies | 36 |
90 | autoantibodies | 839 |
91 | gammopathies | 1 |
92 | immuno-therapies | 1 |
93 | heronries | 1 |
94 | videophones | 8 |
95 | allotypes | 7 |
96 | subisotypes | 2 |
97 | rotaviruses | 33 |
98 | dragées | 1 |
99 | iggs | 23 |
100 | ivigs | 9 |
101 | plasmocytosis | 1 |
102 | chalks | 14 |
103 | storybooks | 3 |
104 | monoclonals | 3 |
105 | thioacetals | 2 |
106 | caramels | 9 |
107 | iga-levels | 5 |
108 | hydroxyls | 8 |
109 | ultrafiltration-ms | 1 |
110 | mitocans | 5 |
111 | allo-antigens | 2 |
112 | paraproteins | 3 |
113 | luteotrophins | 3 |
114 | isoagglutinins | 5 |
115 | histatins | 2 |
116 | precipitins | 3 |
117 | cross-inhibitions | 1 |
118 | anti-inos | 2 |
119 | cseps | 2 |
120 | anti-omps | 2 |
121 | physician-researchers | 5 |
122 | bilirubinometers | 1 |
123 | calibrators | 9 |
124 | sensitivity/responsiveness | 2 |
125 | cytotoxic-hyporesponsiveness | 1 |
126 | immunosorbents | 1 |
127 | prist | 5 |
128 | 0.5u | 2 |
129 | stomat-spray | 3 |
130 | amount/frequency | 1 |
131 | gammopathy | 35 |
132 | anteroposteriorly | 1 |
133 | bilirubinometry | 2 |
134 | release-activity | 1 |
135 | seroreactivity | 26 |